First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study
- Lenz, H.-J.
- Van Cutsem, E.
- Luisa Limon, M.
- Wong, K.Y.M.
- Hendlisz, A.
- Aglietta, M.
- García-Alfonso, P.
- Neyns, B.
- Luppi, G.
- Cardin, D.B.
- Dragovich, T.
- Shah, U.
- Abdullaev, S.
- Gricar, J.
- Ledeine, J.-M.
- Overman, M.J.
- Lonardi, S.
ISSN: 1527-7755
Year of publication: 2022
Volume: 40
Issue: 2
Pages: 161-170
Type: Article